Literature DB >> 21990017

Persistence of uropathogenic Escherichia coli strains in the host for long periods of time: relationship between phylogenetic groups and virulence factors.

A Narciso1, F Nunes, T Amores, L Lito, J Melo-Cristino, A Duarte.   

Abstract

Escherichia coli cause the majority of urinary tract infections (UTIs). Virulence plays an important role in the initial stages of interaction with the host, facilitating colonization of the urinary tract tissue. The purpose of this study was to assess whether there is a relationship between virulence and antibiotic resistance in the persistence of uropathogenic E. coli strains. This study included five patients with UTI between 2001 and 2009. The antibiotic resistance phenotype of 29 E. coli isolates was determined by the disk diffusion method. Clonal relationship was determined through M13 polymerase chain reaction (PCR) fingerprinting. Phylogeny, virulence factors, β-lactamases, and replicon typing were studied through PCR. Antibiogram profiles were found from different patients and corresponded to CTX-M-2, CTX-M-15, CTX-M-32, and TEM-52 enzymes. Plasmids belonged essentially to incompatibility group IncF. No clonal relationship was observed among isolates from different patients, except for patients 4 and 5. Phylogenetic group A was predominant. Our work showed that commensal group A possesses the same virulence factors as the pathogenic groups B1 and D. E. coli common pilus and type 1 fimbriae could play an important role in the persistence in the host and in symptomatic UTI, respectively, which, combined with extended-spectrum β-lactamases (ESBLs), are a cause of the dissemination of microorganisms in the hospital and the community.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990017     DOI: 10.1007/s10096-011-1431-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  35 in total

1.  Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.

Authors:  R Colodner; W Rock; B Chazan; N Keller; N Guy; W Sakran; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

2.  First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal.

Authors:  T Conceição; A Brízio; A Duarte; L M Lito; J Melo Cristino; M J Salgado
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 3.  The CTX-M beta-lactamase pandemic.

Authors:  Rafael Cantón; Teresa M Coque
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

4.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

5.  A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae.

Authors:  C Poyart; P Mugnier; G Quesne; P Berche; P Trieu-Cuot
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

Review 6.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

7.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

8.  Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp.

Authors:  H J Grundmann; K J Towner; L Dijkshoorn; P Gerner-Smidt; M Maher; H Seifert; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

9.  Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001.

Authors:  James R Johnson; Michael A Kuskowski; Abby Gajewski; Daniel F Sahm; James A Karlowsky
Journal:  J Infect Dis       Date:  2004-10-07       Impact factor: 5.226

10.  Uropathogenic E. coli adhesin-induced host cell receptor conformational changes: implications in transmembrane signaling transduction.

Authors:  Huaibin Wang; Guangwei Min; Rudi Glockshuber; Tung-Tien Sun; Xiang-Peng Kong
Journal:  J Mol Biol       Date:  2009-07-03       Impact factor: 5.469

View more
  5 in total

1.  ESBL/pAmpC-Producing Escherichia coli Causing Urinary Tract Infections in Non-Related Companion Animals and Humans.

Authors:  Adriana Belas; Cátia Marques; Juliana Menezes; Luís Telo da Gama; Patrícia Cavaco-Silva; Constança Pomba
Journal:  Antibiotics (Basel)       Date:  2022-04-22

2.  Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients.

Authors:  Yalda Malekzadegan; Reza Khashei; Hadi Sedigh Ebrahim-Saraie; Zahra Jahanabadi
Journal:  BMC Infect Dis       Date:  2018-11-15       Impact factor: 3.090

3.  Molecular characterization and drug resistance of Escherichia coli strains isolated from urine from long-term care facility residents in Cracow, Poland.

Authors:  Monika Pobiega; Jadwiga Wojkowska-Mach; Agnieszka Chmielarczyk; Dorota Romaniszyn; Paweł Adamski; Piotr B Heczko; Barbara Gryglewska; Tomasz Grodzicki
Journal:  Med Sci Monit       Date:  2013-05-01

4.  Identification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico.

Authors:  Daniela A López-Banda; Erika M Carrillo-Casas; Margarita Leyva-Leyva; Gabriel Orozco-Hoyuela; Ángel H Manjarrez-Hernández; Sara Arroyo-Escalante; David Moncada-Barrón; Silvia Villanueva-Recillas; Juan Xicohtencatl-Cortes; Rigoberto Hernández-Castro
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

5.  In vivo mRNA profiling of uropathogenic Escherichia coli from diverse phylogroups reveals common and group-specific gene expression profiles.

Authors:  Piotr Bielecki; Uthayakumar Muthukumarasamy; Denitsa Eckweiler; Agata Bielecka; Sarah Pohl; Ansgar Schanz; Ute Niemeyer; Tonio Oumeraci; Nils von Neuhoff; Jean-Marc Ghigo; Susanne Häussler
Journal:  MBio       Date:  2014-08-05       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.